Although knockout of NF2 is expected to strongly increase YAP/TAZ activity in most cell lines, only a fraction of cell lines show enhanced proliferation upon NF2 knockout in pan-cancer CRISPR proliferation screens (Fig. S5a), suggesting that not all cancer lines are sensitive to YAP activation to the same degree. The gene discussed is NF2; the disease is cancer.